Care9

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Performance Analysis of Medical Representative | Analyzing Reports & Data by...

June 24, 2023

Role and Responsibilities of a Regional Sales Manager | 2nd Line...

April 5, 2020

Mistakes Manager Makes During Job Interviews – Critical and Common Interview...

April 16, 2020

HOT NEWS

Upcoming Events

SuccessTrack – A MedicoMarket Initiative for Freshers

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Interview Questions

Interview Questions – Area Manager in Pharmaceutical Companies

Interview Questions